NCT05670496

Brief Summary

Background: People with hearing, balance, and taste, smell, voice, speech, language, and other Ear, Nose, and Throat (ENT) disorders may seek treatment at the National Institute on Deafness and Other Communication Disorders (NIDCD). Some of these people may benefit from enrolling in the NIDCD intramural research program to receive their care. Enrolling will also allow investigators to collect participants clinical data and specimens for future research. Objective: This natural history study has 2 goals: (1) to collect data and specimens that may be used for research; and (2) to evaluate participants who may be candidates for other research studies. Eligibility: People aged 2 years or older with a hearing, balance, and communication disorder. Those at risk or who are suspected of having such a disorder are also eligible. Design: Participants will be screened. Their medical records will be reviewed. Participants will agree to have their medical data used for research. Specimens such as blood or other tissue samples may also be used for research. All data and specimens will be collected during their routine care visits. All tests done will be the normal care for each participant s condition. No tests will be done solely for research. Some of these tests may require blood or tissue samples. Some may use special tools to test hearing and balance. Some may test heart or lung function. These tests may also include different types of imaging scans. All tests will be explained. Participants may ask questions at any time. Participants may remain in this study for up to 2 years. If they need further care, they may sign a new consent. ...

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
80mo left

Started Mar 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress33%
Mar 2023Dec 2032

First Submitted

Initial submission to the registry

December 31, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 4, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

March 8, 2023

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
6.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2032

Last Updated

April 28, 2026

Status Verified

April 24, 2026

Enrollment Period

3.4 years

First QC Date

December 31, 2022

Last Update Submit

April 25, 2026

Conditions

Keywords

DeafnessHearingSpeechVestibularAudiologyNatural History

Outcome Measures

Primary Outcomes (2)

  • Clinical data collection

    To collect clinical data or specimens generated in the diagnosis and treatment of hearing, balance and communication disorders

    Ongoing

  • Evaluation for clinical studies

    To evaluate patients to determine candidacy for intramural clinical studies

    Ongoing

Study Arms (1)

Patients

Patients at risk, suspected of having, have a history of, or currently have a diagnosed hearing, balance or communication disorder.

Eligibility Criteria

Age2 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients at risk, suspected of having, have a history of, or currently have a diagnosed hearing, balance and communication disorders referred to NIDCD Clinical Investigators by the Intramural Consult Service or community providers

You may qualify if:

  • In order to be eligible to participate in this study, an individual must meet all of the following criteria:
  • Patients must be age 2 years or older if procedures or treatment are required.
  • Patients at risk, suspected of having, have a history of, or currently have a diagnosed hearing, balance, taste, smell, voice, speech, language, and other ENT disorder.
  • An NIDCD clinical investigator and PI determines it is in the interest of the patient/individual and NIDCD CRP for the subject to undergo consult, treatment or follow-up at the NIDCD/NIH
  • Patient or their Legally Authorized Representative is able to provide informed consent. The consent form will be signed by parents or guardians of patients under the age of 18.
  • A subset of enrolled participants with known or suspected PIEZO2-related sensory dysfunction may be asked to participate in the remote taste and oral somatosensory testing procedures. Participation in this component is optional and not required for enrollment or continued participation in the parent protocol.

You may not qualify if:

  • An individual who meets any of the following criteria will be excluded from participation in this study:
  • Candidates who in the opinion of the PI and clinical team have medical or unstable conditions for which NIDCD and CC consultative services are unable to provide or support optimal care
  • Active oral sores, open cuts, or significant oral pain
  • Recent oral surgery or dental procedures within the past 7 days
  • Known allergy or hypersensitivity to tannins or polyphenols
  • Acute upper respiratory infection or conditions that may interfere with taste perception

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States

RECRUITING

Related Links

MeSH Terms

Conditions

Hearing LossDeafnessSpeech

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsVerbal BehaviorCommunicationBehavior

Study Officials

  • Joshua M Levy, M.D.

    National Institute on Deafness and Other Communication Disorders (NIDCD)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marcia L Mulquin, R.N.

CONTACT

Joshua M Levy, M.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 31, 2022

First Posted

January 4, 2023

Study Start

March 8, 2023

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

December 1, 2032

Last Updated

April 28, 2026

Record last verified: 2026-04-24

Locations